1. geal4313
2. byardstreet
3. acam6505
4. pilfer19
5. kinderreadypuent
1.byardstreet 02/28/2018
BioCryst Announces Initiation of the APeX-S Long-Term Safety Trial of BCX7353 in Patients with Hereditary Angioedema
2.acam6505 02/18/2018
Great Point Partners, LLC Opposes The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.
3.pilfer19 06/25/2018
BioCryst Reports Agreement with PMDA on Phase 3 Clinical Trial and Regulatory Requirements for Marketing Authorization of BCX7353 in Japan
4.geal4313 01/26/2018
Global Pharmaceutical Over-the-counter Latest Advancements Boosting OTC Drugs Market Growth
5.byardstreet 01/23/2018
Double for the price target here of $10
6.geal4313 01/23/2018
More merger info: BioCryst Pharmaceuticals and Idera Pharmaceuticals Announce Merger to Combine Capabilities to Serve More Patients with Rare Diseases
7.byardstreet 06/05/2018
BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera
8.geal4313 01/22/2018
BioCryst Pharmaceuticals Merging
9.byardstreet 07/26/2018
BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine
10.geal4313 02/27/2018
BioCryst Reports Fourth Quarter and Full Year 2017 Financial Results
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW